Related Experiment Video
Updated: Dec 12, 2025

09:33
Methods to Classify Cytoplasmic Foci as Mammalian Stress Granules
Published on: May 12, 2017
14.9K
Stress Granules in Cancer
Min-Seok Song1, Elda Grabocka2
1Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
Reviews of Physiology, Biochemistry and Pharmacology
|August 14, 2020
Summary
Stress granules (SGs) are membraneless organelles that form under cellular stress. Aberrant SG formation is linked to cancer, promoting tumor growth and drug resistance, making them a potential therapeutic target.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Cells organize biochemical reactions using organelles, often membrane-bound.
- Membraneless organelles, like stress granules (SGs), form via liquid-liquid phase separation in response to stimuli.
- Altered SG formation is implicated in stress-related diseases, including cancer.
Purpose of the Study:
- To explore the role of stress granules in tumorigenesis.
- To investigate the link between SGs and cancer cell fitness.
- To identify SGs as potential therapeutic targets in cancer.
Main Methods:
- Review of recent evidence on SG formation and function.
- Analysis of signaling pathways (e.g., RAS, mTOR, HDAC6) influencing SG dynamics.
- Examination of SG roles in cancer cell proliferation, invasion, metastasis, and drug resistance.
Main Results:
- Pro-tumorigenic signaling molecules upregulate SG formation.
- SGs integrate oncogenic signaling and stress stimuli, enhancing cancer cell fitness.
- SGs regulate cell survival/death and contribute to cancer progression and drug resistance.
Conclusions:
- Stress granules are key regulatory hubs in cancer.
- SGs play multifaceted roles in tumorigenesis, from survival to metastasis.
- Targeting SGs presents a promising therapeutic strategy for cancer treatment.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Cancer Cell Migration through Invadopodia
3.0K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.0K
Cancer Stem Cells and Tumor Maintenance
5.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.7K
Metastasis
6.2K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K
Adaptive Mechanisms in Cancer Cells
6.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K
Mitogens and the Cell Cycle
7.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K

